DOJ v. NewYork-Presbyterian - Hospital Antitrust Contract Restrictions
Summary
The DOJ Antitrust Division filed a civil lawsuit against NewYork-Presbyterian (NYP) in the US District Court for the Southern District of New York, alleging violations of Section 1 of the Sherman Act. The complaint alleges NYP's contracts with commercial payors contain 'all-or-nothing' and most favored nation provisions that prevent development of budget-conscious health plans. This marks the second DOJ antitrust action against hospital system contracting practices in 2026, following a similar suit against OhioHealth.
What changed
DOJ alleges that NYP's 'all-or-nothing' contracting model and requirement to be featured at the most favored benefit level in each payor's plans unlawfully restrains competition in inpatient general acute care hospital services. The complaint identifies two geographic marketsโManhattan and the Four-Borough regionโwith NYP holding alleged market shares exceeding 30% and 25% respectively. DOJ claims these provisions prevented payors from implementing narrow network plans, tiered networks, centers of excellence programs, and site-of-service steering mechanisms.
Healthcare systems should review their payor contracting practices for similar 'all-or-nothing' provisions and most favored nation clauses that restrict payors' ability to design cost-conscious plan options. The DOJ's complaint closely mirrors its February 2026 suit against OhioHealth, signaling a pattern of enforcement targeting hospital contracting restrictions. NYP and other health systems with significant market presence should anticipate continued antitrust scrutiny of provisions that limit competitive alternatives for employers and patients. The case is filed as Civil Action No. in SDNY.
What to do next
- Review payor contracts for 'all-or-nothing' or most favored nation provisions that may restrict payor plan design flexibility
- Assess whether current contracting practices could be characterized as limiting budget-conscious plan options
- Monitor DOJ enforcement patterns following NYP and OhioHealth cases for industry-wide implications
Penalties
Potential injunctive relief requiring contract modifications; treble damages exposure in private follow-on litigation
Archived snapshot
Apr 1, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
April 1, 2026
DOJ Continues Scrutiny of Health System Contracting in Second 2026 Antitrust Case
LinkedIn Facebook X Send Embed
The US Department of Justice Antitrust Division (DOJ) in March 2026 brought an antitrust action against NewYork-Presbyterian (NYP), alleging that the health systemโs contracts with commercial payors restrict โbudget-conscious plansโ and are anticompetitive under the federal antitrust laws. The suit follows a similar recent action against OhioHealth and demonstrates DOJโs commitment to challenging certain payor-provider contract restrictions that it believes limits the availability of more cost-effective healthcare plans for employers and patients.
On March 26, 2026, DOJ filed a civil lawsui t against NYP in the US District Court for the Southern District of New York, alleging violations of Section 1 of the Sherman Act. DOJ alleges that NYP unlawfully restrains competition in the market for inpatient general acute care hospital services by contracting with payors on an โall-or-nothing basisโ and requiring that NYP be featured at the most favored level of benefits in each plan. According to DOJ, these โillegal contractual plan design restrictionsโ protect NYPโs market share, prevent rivals and potential entrants from competing on price to attract patients, result in fewer insurance plans for consumers to choose from, and increase costs for employers and patients.
DOJ further alleges that these restrictions prevented payors from using the following โtoolsโ to develop โbudget-conscious plansโ:
- Narrow network plans: Healthcare plans with a relatively limited set of cost-effective providers
- Tiered network plans: Lower out-of-pocket expenses for members in broad networks who choose cost-effective providers in the preferred tier within the network
- Centers of excellence: Programs that incentivize members to obtain certain healthcare services from designated groups of providers that offer better value
- Site of service steering: Incentives for members to choose lower-cost locations, such as ambulatory surgery centers, over higher-cost locations, such as hospitals DOJโs complaint defines two geographic marketsโ(1) a Manhattan market and (2) a combined Manhattan-Queens-Brooklyn-Bronx (Four-Borough) marketโand alleges that NYP has market shares exceeding 30% and 25% in those alleged markets, respectively. These alleged market shares are relatively low for establishing market power in antitrust litigation. However, DOJ claims that NYPโs size, brand, and reputation give it market power because a payor selling health insurance plans to individuals or employers in these alleged geographic markets must have NYP as a participant in at least some of its provider networks to have successful health insurance products.
DOJโs complaint against NYP closely resembles the lawsuit it and the Ohio Attorney General filed against an Ohio health system just last month. In its suit against OhioHealth, DOJ similarly alleges that the health systemโs contracting practices with payors prevented payors from offering the tools discussed above. Both the suit against NYP and the suit against OhioHealth represent a revival of interest in challenging health systemsโ allegedly restrictive contracting practicesโlast seen in 2016, when DOJ and the North Carolina Attorney General sued Carolinas HealthCare System (now Atrium Health). DOJ ultimately resolved its suit against Carolinas HealthCare System through a negotiated settlement requiring modifications to Carolinasโ contracting practices.
KEY TAKEAWAYS
- This is DOJโs second action in 2026 challenging contractual restrictions that may inhibit the development of โbudget-conscious plans,โ such as narrow and tiered network plans. Healthcare provider networks and hospital systemsโparticularly those with substantial market sharesโshould consider whether provisions in their contracts with payors could expose them to potential antitrust risk.
- The complaints against NYP and OhioHealth allege relatively modest market shares (25โ35%) and signal increased aggressiveness by DOJ to challenge potentially anticompetitive conduct even in the absence of traditionally high market shares alleged in prior litigation. Accordingly, healthcare systems should be aware that the contract restriction described above may be challengedโeven when the healthcare system lacks a traditionally high market share.
- Alongside the Federal Trade Commissionโs announcement this week that it is establishing a Healthcare Task Force, these cases signal that healthcare is a high priority for the federal antitrust agencies in this administration. [View source.]
Related Posts
- DOJ Lawsuit Against OhioHealth Alleges Anticompetitive Contract Restrictions with Payors
- DOJ Issues Unified Corporate Enforcement Policy
- Deputy Assistant Attorney General Brenna Jenny Offers Insight on DOJ Civil Rights Fraud Enforcement
Latest Posts
- Moving the Goalposts: Key Employment Law Updates for Football Clubs
- Powering Data Centers: Energy Strategy and Structuring for a Constrained Grid See more ยป
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.
ยฉ
Morgan Lewis
2026
Written by:
Morgan Lewis Contact + Follow Zachary Johns + Follow Ryan Kantor + Follow B. Scott McBride + Follow Vincent Papa + Follow Nicholas Pfeiffer + Follow
PUBLISH YOUR CONTENT ON JDย SUPRA
- โ Increased readership
- โ Actionable analytics
- โ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra
Published In:
Anticompetitive Agreements + Follow Antitrust Division + Follow Antitrust Litigation + Follow Antitrust Violations + Follow Competition + Follow Department of Justice (DOJ) + Follow Enforcement Actions + Follow Federal Trade Commission (FTC) + Follow Health Care Providers + Follow Health Insurance + Follow Healthcare + Follow Hospitals + Follow Insurance Contracts + Follow Sherman Act + Follow Antitrust & Trade Regulation + Follow Health + Follow Insurance + Follow more
Morgan Lewis on:
Solve with 2Captcha
Solve with 2Captcha
Named provisions
Related changes
Get daily alerts for JD Supra Healthcare
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from DOJ ATR.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when JD Supra Healthcare publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.